Abdominal obesity was independently associated with recurrent MI or stroke despite secondary preventive measures, according to a new study.
The novel test was shown to be effective in the early detection of symptom-free patients with coronary artery disease.
Use of ticagrelor post-PCI was not associated with reduced risk for MACE vs clopidogrel, a reversal of results seen in the landmark PLATO trial.
Dyslipidemia guidelines from the US and Europe take slightly different routes to similar ends. Test your knowledge of the twists and turns.
Cardiovascular diseases, particularly heart failure, were found significantly and independently associated with end-stage renal disease in a new analysis.
Dapagliflozin received FDA priority review for reducing risk of CV death in adults with heart failure with reduced ejection fraction.
From measles resurgence to new CVD guidelines, refresh your memory of this year’s highlights with our quiz on the most-read content on Patient Care®.
ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.
Depression & anxiety in COPD patients respond well to pulmonary rehabilitation but how to proceed safely in patients with comorbid CVD?
AHA Scientific Sessions 2019: In SIHD patients with moderate-severe ischemia, initial revascularization + OMT compared to OMT alone did not reduce the risk for adverse CV outcomes